Lenz (LENZ) Q2 Revenue Jumps 604%
LENZ Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $7.78
+17% in 7d after detection
Post-detection moves
1h
—
1d
+8.3%
3d
+14%
7d
+17%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS